Related Experiment Videos

Visualization of left atrial appendage and assessment of its function by transthoracic second harmonic imaging and

M Pozzoli1, A Selva, D Skouse

  • 1Department of Cardiology, A. Manzoni Hospital, Lecco, Italy. maxpozz@libero.it

Insights

Transthoracic echocardiography with contrast reliably measures left atrial appendage flow velocity, aiding thromboembolism risk assessment in atrial fibrillation patients. This non-invasive method shows promise for serial screening.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Echocardiography

Background:

  • Low flow velocity in the left atrial appendage (LAA) predicts thromboembolism and cardioversion failure in atrial fibrillation.
  • Transoesophageal echocardiography (TEE) assesses LAA flow but is limited for serial screening due to its invasive nature.

Purpose of the Study:

  • To evaluate transthoracic echocardiography (TTE) with second harmonic imaging and Doppler, including contrast enhancement, for assessing LAA visualization and flow velocity.
  • To compare TTE findings with transoesophageal echocardiography (TEE) in patients with atrial fibrillation.

Main Methods:

  • Investigated 51 patients undergoing TEE using transthoracic second harmonic imaging and pulsed Doppler with and without Levovist contrast.
  • Assessed LAA visualization, flow velocity measurements, and thrombus detection.
  • Correlated TTE and TEE measurements of peak emptying velocity and flow patterns.

Main Results:

  • LAA was visualized by TTE in 46/51 patients; interpretable Doppler tracings were obtained in 39 at baseline and 45 with contrast.
  • Peak emptying velocity correlations were 0.81 (standard TTE) and 0.91 (contrast TTE) versus TEE.
  • Agreement in flow velocity patterns between contrast TTE and TEE was 93%; contrast TTE identified low flow (<30cm/s) in most patients with LAA thrombus or spontaneous contrast on TEE.

Conclusions:

  • Transthoracic echocardiography with second harmonic imaging and pulsed Doppler can visualize the LAA and reliably measure flow velocity in many patients.
  • Contrast enhancement significantly improves the feasibility and accuracy of TTE for evaluating LAA flow velocity.
  • Prospective studies are needed to confirm the clinical utility of this non-invasive method for predicting thromboembolic risk and cardioversion success.
Abstract

Related Concept Videos